Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

As thousands of people await a lifesaving heart, scientists are racing to buy them more time. A promising advance from scientists in Germany offers a potential solution.

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in ...

The identification and management of comorbidities are central to the care of patients with atrial fibrillation (AF). The ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing ...

A team of scientists led by Northwestern Medicine investigators have uncovered new details about a deadly heart condition ...

Did you know men and women's heart cells prefer different kinds of fuel? Gender differences are emerging as scientists turn ...

The decision to move forward with a heart transplant is made when all other treatment options been unsuccessful.

Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...